Dyax - Advancing Novel Biotherapeutics

Spotlight

Dyax Corp. Announces Third Quarter 2009 Financial Results Learn More

Dyax Announces New Developments Related to Phage Display-Discovered Drug Candidates Learn More

Reliability and Validity of Dyax's Novel Patient Reported Outcome Measures (PROs) Affirmed in Published Study
Learn More

See Important Safety Information and Full Prescribing Information including Boxed Warning and Medication Guide on www.KALBITOR.com

 

At the core of our success is our powerful and proprietary drug discovery technology, phage display.

 

Learn More